GS
72
-8
DHR
61
5
HBAN
57
3
GWW
64
6
HP
32
-2
MTB
56
-3
HES
67
-3
PFE
40
3
ETR
65
2
IP
62
-2
AME
63
3
USB
46
2
IRM
76
5
MDLZ
51
-2
GOOG
73
2
CINF
53
-3
TRV
45
-4
DTE
50
3
MSFT
64
2
PHM
74
5
GS
72
-8
DHR
61
5
HBAN
57
3
GWW
64
6
HP
32
-2
MTB
56
-3
HES
67
-3
PFE
40
3
ETR
65
2
IP
62
-2
AME
63
3
USB
46
2
IRM
76
5
MDLZ
51
-2
GOOG
73
2
CINF
53
-3
TRV
45
-4
DTE
50
3
MSFT
64
2
PHM
74
5
Financhill
Back

Supernus Pharmaceuticals Vs. Esperion Therapeutics Industry Stock Comparison

Sell
31

SUPN
Supernus Pharmaceuticals

Last Price:
29.25
Seasonality Move:
14.18%
Sell
39

ESPR
Esperion Therapeutics

Last Price:
2.59
Seasonality Move:
-7.21%
Sell
31
Supernus Pharmaceuticals (SUPN) is a Sell

Is Supernus Pharmaceuticals a Buy, Sell or Hold?

  • The current Supernus Pharmaceuticals [SUPN] share price is $28.74. The Score for SUPN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SUPN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Esperion Therapeutics (ESPR) is a Sell

Is Esperion Therapeutics a Buy, Sell or Hold?

  • The current Esperion Therapeutics [ESPR] share price is $2.30. The Score for ESPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ESPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SUPN Stock Price Chart

What is Supernus Pharmaceuticals's stock price today?

  • The Supernus Pharmaceuticals share price today is $28.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.

ESPR Stock Price Chart

What is Esperion Therapeutics's stock price today?

  • The Esperion Therapeutics share price today is $2.30
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SUPN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 39.72 Sell
Chaikin Money Flow: -306562 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.18 - 30.78) Sell
Bollinger Bands (100): (27.87 - 32.19) Sell

ESPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 54.17 Buy
Chaikin Money Flow: 5586939 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.93 - 2.21) Buy
Bollinger Bands (100): (2.05 - 2.73) Sell

SUPN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.91 Sell
20-day SMA: 29.94 Sell
50-day SMA: 31.56 Sell
200-day SMA: 29.07 Sell
8-day EMA: 29.58 Sell
20-day EMA: 30.1 Sell
50-day EMA: 30.5 Sell
200-day EMA: 30.2 Sell

ESPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.19 Buy
20-day SMA: 2.08 Buy
50-day SMA: 2.28 Buy
200-day SMA: 1.83 Buy
8-day EMA: 2.19 Buy
20-day EMA: 2.17 Buy
50-day EMA: 2.24 Buy
200-day EMA: 2.26 Buy

Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.19 per share, and an increase next year of $0.58 per share.

Esperion Therapeutics Earnings Growth & ESPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.08 per share, an increase this year of $2.00 per share, and an increase next year of $0.23 per share.

Supernus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Esperion Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):